139 related articles for article (PubMed ID: 25607432)
1. A biologic Velcro patch.
Tolar J; Wagner JE
N Engl J Med; 2015 Jan; 372(4):382-4. PubMed ID: 25607432
[No Abstract] [Full Text] [Related]
2. An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking P; Koller U; Duarte B; Murillas R; Wolf S; Maetzig T; Rothe M; Kocher T; García M; Brachtl G; Schambach A; Larcher F; Reichelt J; Bauer JW; Murauer EM
Nucleic Acids Res; 2017 Sep; 45(17):10259-10269. PubMed ID: 28973459
[TBL] [Abstract][Full Text] [Related]
3. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Itoh M; Kawagoe S; Tamai K; Nakagawa H; Asahina A; Okano HJ
J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
[TBL] [Abstract][Full Text] [Related]
4. siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.
Pendaries V; Gasc G; Titeux M; Tonasso L; Mejía JE; Hovnanian A
J Invest Dermatol; 2012 Jun; 132(6):1741-3. PubMed ID: 22336946
[No Abstract] [Full Text] [Related]
5. Targeted skipping of a single exon harboring a premature termination codon mutation: implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients.
Goto M; Sawamura D; Nishie W; Sakai K; McMillan JR; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Dec; 126(12):2614-20. PubMed ID: 16778792
[TBL] [Abstract][Full Text] [Related]
6. A mutation-independent therapeutic strategy for dominant dystrophic epidermolysis bullosa.
Morgan CP; Allen DSI; Millington-Ward S; O'Dwyer GE; Palfi A; Jane Farrar G
J Invest Dermatol; 2013 Dec; 133(12):2793-2796. PubMed ID: 23743647
[No Abstract] [Full Text] [Related]
7. Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector (GENEGRAFT).
Hum Gene Ther Clin Dev; 2014 Jun; 25(2):65-6. PubMed ID: 24933565
[No Abstract] [Full Text] [Related]
8. Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa.
Tolar J; McGrath JA; Xia L; Riddle MJ; Lees CJ; Eide C; Keene DR; Liu L; Osborn MJ; Lund TC; Blazar BR; Wagner JE
J Invest Dermatol; 2014 May; 134(5):1246-1254. PubMed ID: 24317394
[TBL] [Abstract][Full Text] [Related]
9. Revertant mosaicism in recessive dystrophic epidermolysis bullosa.
Almaani N; Nagy N; Liu L; Dopping-Hepenstal PJ; Lai-Cheong JE; Clements SE; Techanukul T; Tanaka A; Mellerio JE; McGrath JA
J Invest Dermatol; 2010 Jul; 130(7):1937-40. PubMed ID: 20357813
[No Abstract] [Full Text] [Related]
10. Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
Wenzel D; Bayerl J; Nyström A; Bruckner-Tuderman L; Meixner A; Penninger JM
Sci Transl Med; 2014 Nov; 6(264):264ra165. PubMed ID: 25429058
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy for a genetic skin disease.
Bruckner-Tuderman L
N Engl J Med; 2010 Aug; 363(7):680-2. PubMed ID: 20818860
[No Abstract] [Full Text] [Related]
12. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
13. [Recessive dystrophic bullous epidermolysis: Is the etiological treatment at the streetcorner?].
Dereure O
Ann Dermatol Venereol; 2011 Oct; 138(10):710-1. PubMed ID: 21978513
[No Abstract] [Full Text] [Related]
14. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte cell lines derived from severe generalized recessive epidermolysis bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo.
Chamorro C; Almarza D; Duarte B; Llames SG; Murillas R; García M; Cigudosa JC; Espinosa-Hevia L; Escámez MJ; Mencía A; Meana A; García-Escudero R; Moro R; Conti CJ; Del Río M; Larcher F
Exp Dermatol; 2013 Sep; 22(9):601-3. PubMed ID: 23947675
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Hovnanian A
Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
[TBL] [Abstract][Full Text] [Related]
17. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
[TBL] [Abstract][Full Text] [Related]
18. Functional correction of type VII collagen expression in dystrophic epidermolysis bullosa.
Murauer EM; Gache Y; Gratz IK; Klausegger A; Muss W; Gruber C; Meneguzzi G; Hintner H; Bauer JW
J Invest Dermatol; 2011 Jan; 131(1):74-83. PubMed ID: 20720561
[TBL] [Abstract][Full Text] [Related]
19. A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa.
Cutlar L; Zhou D; Hu X; Duarte B; Greiser U; Larcher F; Wang W
Exp Dermatol; 2016 Oct; 25(10):818-20. PubMed ID: 27117059
[No Abstract] [Full Text] [Related]
20. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
